wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35008618-92425514-9A0A-4776-813B-F74E86210E02
Q35008618-92425514-9A0A-4776-813B-F74E86210E02
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35008618-92425514-9A0A-4776-813B-F74E86210E02
Safety of bosutinib versus imatinib in the phase 3 BELA trial in newly diagnosed chronic phase chronic myeloid leukemia.
P2860
Q35008618-92425514-9A0A-4776-813B-F74E86210E02
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35008618-92425514-9A0A-4776-813B-F74E86210E02
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7c95fad5ac500ecaa2554dfdacc6589c0d0b8fdf
P2860
Bosutinib is active in chronic phase chronic myeloid leukemia after imatinib and dasatinib and/or nilotinib therapy failure